The abstract is read at the publisher; the summary is JClub's.
ITH15004 significantly improved MTT-reducing activity in NSC-34 motor neuron-like cells exposed to extracellular ATP (1 mM), oligomycin/rotenone, and nigericin (5 uM).
- Why it matters: ALS involves mitochondrial dysfunction, oxidative stress, calcium dysregulation, and neuroinflammation, yet effective therapies remain limited. Testing purinergic receptor modulation may help address these converging stress pathways.
- What they did: NSC-34 cells were stressed with oligomycin (10 uM) plus rotenone (30 uM), nigericin (5 uM), or extracellular ATP (1 mM), then treated with ITH15004. Metabolic activity (MTT), apoptosis (caspase-3/7), intracellular ATP, cytosolic calcium, and cytochrome c and VDAC1 protein abundance were measured.
- The result: ITH15004 partially restored intracellular ATP after nigericin and significantly reduced nigericin-induced caspase-3/7 activation, with Western blot changes in cytochrome c and VDAC1. These results suggest ITH15004 attenuates stress- and apoptosis-linked damage in this cell model.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.